{"id": "397481", "url": "https://fevir.net/resources/Evidence/397481", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparative-evidence"], "versionId": "9", "lastUpdated": "2025-11-30T11:12:35.941Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p><b>Title: </b>Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan</p><p><b>Variable in role of population: </b>the study group</p><p><b>Variable in role of exposure: </b>GroupAssignment: Quadpill vs. Candesartan</p><p><b>Variable in role of outcome: </b>Medication Adherence at 12 weeks</p><p><b>Statistic: </b>odds ratio (coded as: STATO:0000182 from https://fevir.net/sevco) 0.37</p></div>", "status": "generated"}, "title": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "author": [{"name": "Brian S. Alper, MD, MSPH"}], "citeAs": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397481. Revised 2025-11-30. Available at: https://fevir.net/resources/Evidence/397481. Computable resource at: https://fevir.net/resources/Evidence/397481#json.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "publisher": "Computable Publishing LLC", "relatesTo": [{"type": "part-of", "targetReference": {"type": "Composition", "display": "Outcome Measure Report for QUARTET USA Trial", "reference": "Composition/375280"}}], "statistic": [{"quantity": {"value": 0.37}, "sampleSize": {"knownDataCount": 53, "numberOfParticipants": 62}, "statisticType": {"coding": [{"code": "STATO:0000182", "system": "https://fevir.net/sevco", "display": "odds ratio"}]}, "attributeEstimate": [{"type": {"coding": [{"code": "STATO:0000196", "system": "https://fevir.net/sevco", "display": "confidence interval"}]}, "level": 0.95, "range": {"low": {"value": 0.19}, "high": {"value": 2.08}}}, {"type": {"coding": [{"code": "STATO:0000700", "system": "https://fevir.net/sevco", "display": "p-value"}]}, "quantity": {"value": 0.444}}]}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "397481", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "Evidence", "variableDefinition": [{"observed": {"type": "Group", "display": "Enrolled Group for QUARTET USA Trial", "reference": "Group/372797"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "GroupAssignment: Quadpill vs. Candesartan", "reference": "EvidenceVariable/375183"}, "variableRole": "exposure", "comparatorCategory": "Candesartan 8 mg once daily"}, {"observed": {"type": "EvidenceVariable", "display": "Medication Adherence at 12 weeks", "reference": "EvidenceVariable/375201"}, "variableRole": "outcome"}], "name": "Evidence_for_Results_for_Medication_Adherence_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan", "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."}